Mar 10, 2021 4:04pm EST DiaMedica Therapeutics Announces 2020 Financial Results and Provides a Business Update
Mar 10, 2021 8:52am EST DiaMedica Therapeutics to Present Research at International Stroke Virtual Conference
Mar 09, 2021 4:04pm EST DiaMedica Therapeutics Hosting Key Opinion Leader Webinar on DM199 for Treatment of Acute Ischemic Stroke
Mar 03, 2021 4:04pm EST DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021
Jan 11, 2021 8:00am EST DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Dec 15, 2020 8:04am EST DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
Dec 10, 2020 8:03am EST DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
Nov 19, 2020 9:04am EST DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
